Zebing Liu

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer

Anqi Li, Zebing Liu, Ming Li et al. · Oncotarget · 2016 · 73 citations · Full text

Medicine, Oncology, Pharmacology +15

MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.

Fei Ren, Lisha Wang, Xiaohan Shen et al. · PubMed · 2015 · 64 citations

Medicine, Molecular Biology, Oncology +17

The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic <i>NRG1</i> Fusions

Igor Odintsov, Allan J.W. Lui, Whitney J. Sisso et al. · Clinical Cancer Research · 2021 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +16

BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs

Zebing Liu, Ping Wei, Yu Yang et al. · Clinical Cancer Research · 2015 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +17

Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features

Bing Cao, Ping Wei, Zebing Liu et al. · OncoTargets and Therapy · 2015 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +17